Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
44.56
+0.70 (1.60%)
Jul 26, 2024, 4:30 PM EDT - Market closed

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $2.94 billion as of July 26, 2024. Its market cap has increased by 70.89% in one year.

Market Cap
2.94B
Enterprise Value
2.12B
1-Year Change
70.89%
Ranking
Category
Stock Price
$44.56

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $2.94B, an increase of 1,883.10%. That is a compound annual growth rate of 15.27%.

History

DateMarket Cap% Change
Jul 25, 20242.89B54.22%
Dec 29, 20231.87B-10.70%
Dec 30, 20222.10B16.42%
Dec 31, 20211.80B160.11%
Dec 31, 2020693.20M1,825.56%
Dec 31, 201936.00M5.57%
Dec 31, 201834.10M-91.17%
Dec 29, 2017386.20M7.76%
Dec 30, 2016358.40M-76.83%
Dec 31, 20151.55B-5.39%
Dec 31, 20141.64B-16.73%
Dec 31, 20131.96B372.13%
Dec 31, 2012415.90M262.28%
Dec 30, 2011114.80M-13.10%
Dec 31, 2010132.10M-10.50%
Dec 31, 2009147.60M17.99%
Dec 31, 2008125.10M237.20%
Dec 31, 200737.10M-62.68%
Dec 29, 200699.40M-28.69%
Dec 30, 2005139.40M-6.44%
Dec 31, 2004149.00M-15.96%
Dec 31, 2003177.30M19.72%
View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
QuidelOrtho 2.63B
Vericel 2.60B
Myriad Genetics 2.59B
PTC Therapeutics 2.58B
Intellia Therapeutics 2.54B
UFP Technologies 2.51B
Geron 2.51B
Iovance Biotherapeutics 2.50B
Market Cap Rankings